Back |
home / stock / acad / acad message board
Subject | By | Source | When |
---|---|---|---|
DennyT: ACAD 38.23 Acadia Pharmaceuticals Inc $ACAD Hit a 52 week high of 38.50 Closing the day 09:4 | DennyT | investorshangout | 03/02/2015 3:02:13 PM |
chartguy89: ACAD 37.97 Acadia Pharmaceuticals Inc Stock Charts $ACAD Last Updated: 02/27/15 Last pri | chartguy89 | investorshangout | 02/28/2015 3:48:06 AM |
Jake13: ACAD Stock year to date has changed +19.59% percent. +19.78% in the last 30 days. $ACAD Acad | Jake13 | investorshangout | 02/28/2015 3:39:30 AM |
danrocks: ACAD Stock is number 172 for the largest percentage gain out of 250 stocks. $ACAD ACAD is | danrocks | investorshangout | 02/24/2015 6:26:09 PM |
DennyT: ACAD 38.34 Acadia Pharmaceuticals Inc $ACAD Hit a 52 week high of 38.43 Closing the day 09:4 | DennyT | investorshangout | 02/24/2015 3:04:14 PM |
News, Short Squeeze, Breakout and More Instantly...
ACADIA Pharmaceuticals Inc. Company Name:
ACAD Stock Symbol:
NASDAQ Market:
ACADIA Pharmaceuticals Inc. Website:
Company to host conference call and webcast on Tuesday, August 6, 2024, at 4:30 p.m. Eastern Time Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report second quarter financial results on Tuesday, August 6, 2024, after the close of the U.S. financial markets...
-- Continued Improvements in RSBQ and CGI-I scores seen with long-term DAYBUE treatment in Phase 3 LAVENDER™ and LILAC studies -- DAYBUE safety profile was consistent with findings from the LAVENDER trial Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the...
2024-06-26 17:30:03 ET BMO Capital analyst issues OUTPERFORM recommendation for ACAD on June 26, 2024 04:09PM ET. The previous analyst recommendation was Buy. ACAD was trading at $15.5 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...